4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-22-025099
Chief Financial Officer bought 30,000 shares at $1.56 ($46,710)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levine James E. Chief Financial Officer | 2022-09-16 | Purchase | +30,000 | $1.56 | $46,710 | 60,000 | D: show line 1 in the form |
| Open-market purchases · 30,000 sh · avg $1.56 · $46,710 | |||||||
Loading xslF345X03/wf-form4_166359101233703.xml…